Defining the BURden after surgical ablation therapY for the treatment of Atrial Fibrillation

Defining the BURden after surgical ablation therapY for the treatment of Atrial Fibrillation - BURY-AF

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47756

Enrollment

300

Registered

2016-07-07

Start date

2019-11-18

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -(Longstanding) persisterend or paroxysmal AF -Accepted for thoracoscopic surgical ablation (TT-maze or port-access concomitant left atrial MAZE surgery (heartport)) -18 years or older - The patient is mentally able and willing to give informed consent - The patient agrees with the implantation of an implantable loop recorder

Exclusion criteria

Exclusion criteria: No ILR implantation prior to surgery

Design outcomes

Primary

Measure	Time frame
The primary objective of the study is: - to evaluate the burden of AF and quality of life rhythm after thoracoscopic ablation surgery and after port-access concomitant left atrial MAZE surgery by continuous rhythm monitoring (Medtronic Reveal Linq Insertable Cardiac Monitor*).	—

Secondary

Measure	Time frame
Secondary objectives are: - to evaluate freedom from AF/AFl/AT, - to assess the clinical safety of the procedure - to assess neurologic outcome (ischemic stroke, hemorrhagic stroke, transient ischemic attack) - to evaluate the postoperative biochemical cardio-inflammatory response (NT-pro-BNP, CRP, IL-6 and troponin levels)	—

Countries

Netherlands

Outcome results